1305P Health-related quality of life (HRQoL) in a phase III study of first-line brigatinib (BRG) vs crizotinib (CRZ) in NSCLC: Updated results from ALTA-1L
- Resource Type
- Source
- Annals of Oncology. 31:S844
- Subject
Oncology Health related quality of life medicine.medical_specialty Crizotinib Brigatinib business.industry First line Internal medicine medicine Hematology business medicine.drug - Language
- ISSN
- 0923-7534